{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:05Z","timestamp":1787169545606,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The neurofibromatosis is a large class of different genetic disorders: Neurofibromatosis type 1, type 2, type 3 (or Schwannomatosys), which have different clinical characterization. Neurofibromatosis type 1 (NF1), also known as Von Recklinghausen disease, represents 95% of the total cases. It is a complex autosomal dominant disorder with multisystem involvement, frequently associated to cardiac malformation. We present the case of a 52-years-old male affected by NF-1 with severe tricuspid regurgitation and atrial septal defect (ASD). No previous report about tricuspid valve surgery in NF-1 are available in the literature. A complete perioperative assessment was performed, including dermatologist evaluation, angio-CT scan and transesophageal echocardiography. The patient underwent uneventfully tricuspid valve replacement and ASD closure, with no wound complication even at 6-months follow-up. Treating congenital malformation in patient with complex genetic disorders like NF-1 is safe and can be resolutive, permitting to reduce long-term risk of complications for the patients. Preoperative assessments are fundamental, as well as in-hospital care and expertise on congenital heart defects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/heartviews.heartviews_17_21","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T04:14:37Z","timestamp":1633925677000},"page":"214-219","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["First Case of Tricuspid Valve Surgery in a Neurofibromatosis Type 1 Patient"],"prefix":"10.4103","volume":"22","author":[{"given":"Matteo","family":"Saccocci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Del Zanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zean","family":"Mhagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita Dalla","family":"Tomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Troise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20240902","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"R3-9-20240902","first-page":"714","article-title":"Neurofibromatosis type 1 and cardiac manifestations","volume":"43","author":"\u0130ncecik","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R4-9-20240902","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: A total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R5-9-20240902","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R6-9-20240902","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/genes10090675","article-title":"Prevalence, type, and molecular spectrum of NF1 mutations in patients with neurofibromatosis type 1 and congenital heart disease","volume":"10","author":"Pinna","year":"2019","journal-title":"Genes (Basel"},{"key":"R8-9-20240902","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI41443","article-title":"Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans","volume":"120","author":"Lasater","year":"2010","journal-title":"J Clin Invest"},{"key":"R9-9-20240902","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","article-title":"Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force","volume":"4","author":"Friedman","year":"2002","journal-title":"Genet Med"},{"key":"R10-9-20240902","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1067\/mhj.2002.122121","article-title":"The heart in neurofibromatosis type 1: An echocardiographic study","volume":"143","author":"Tedesco","year":"2002","journal-title":"Am Heart J"},{"key":"R11-9-20240902","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0","article-title":"Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1","volume":"95","author":"Lin","year":"2000","journal-title":"Am J Med Genet"},{"key":"R12-9-20240902","first-page":"111","article-title":"Perioperative management of neurofibromatosis type 1","volume":"12","author":"Fox","year":"2012","journal-title":"Ochsner J"},{"key":"R13-9-20240902","first-page":"739","article-title":"Which type of valve should we use in tricuspid position.Long-term comparison between mechanical and biological valves?","volume":"58","author":"Redondo Palacios","year":"2017","journal-title":"J Cardiovasc Surg (Torino"},{"key":"R14-9-20240902","first-page":"172","article-title":"The better substitute for tricuspid valve replacement in patients with severe isolated tricuspid regurgitation","volume":"22","author":"Liang","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"R15-9-20240902","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jocs.12730","article-title":"Should a mechanical or biological prosthesis be used for a tricuspid valve replacement.A meta-analysis?","volume":"31","author":"Liu","year":"2016","journal-title":"J Card Surg"}],"container-title":["Heart Views"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/HEARTVIEWS.HEARTVIEWS_17_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:12Z","timestamp":1787166492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/HEARTVIEWS.HEARTVIEWS_17_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/heartviews.heartviews_17_21","relation":{},"ISSN":["1995-705X"],"issn-type":[{"value":"1995-705X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}